K V Lobastov Selected Research

Anticoagulants

1/2020	[Peculiarities of the treatment of venous thromboembolism with direct oral anticoagulants in challenging patients: senile age, renal failure, fragility].
1/2019	[Contemporary approaches to determine the duration of anticoagulant therapy for venous thromboembolism].
1/2017	[Anticoagulant therapy of venous thromboembolic complications: balancing between risks].
1/2017	[Clinical efficacy of electric stimulation of crural muscles in comprehensive treatment of post-thrombotic disease].
1/2014	[Treatment of acute deep vein thrombosis with new oral anticoagulant rivaroxaban: the first experience].
1/2013	[Haemodynamic and clinical efficacy of electric muscular stimulation of the venous outflow in prevention of postoperative venous thromboembolic complications].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K V Lobastov Research Topics

Disease

5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017 - 01/2014
4	Venous Thromboembolism 03/2020 - 01/2013
4	Hemorrhage 01/2020 - 01/2014
2	Thrombosis (Thrombus) 01/2019 - 01/2014
1	Neoplasms (Cancer) 03/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Pulmonary Embolism 01/2017
1	Pathologic Constriction (Stenosis) 01/2017

Drug/Important Bio-Agent (IBA)

6	AnticoagulantsIBA 01/2020 - 01/2013
4	RivaroxabanIBA 01/2020 - 01/2014
2	Vitamin K FDA Link 01/2020 - 01/2019
1	apixabanIBA 01/2020
1	Dabigatran FDA Link 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2014
2	Secondary Prevention 03/2020 - 01/2017
2	Duration of Therapy 01/2019 - 01/2014
2	Compression Bandages 01/2014 - 01/2013